Prescription Trends of Hydrochlorothiazide vs. Chlorthalidone in the United States (2019-2024)
The FDA warning and DCP report were associated with a decline in hydrochlorothiazide and chlorthalidone prescriptions, while the DCP report slowed chlorthalidone prescribing.
Authors
- Yara Jelwan (ORCID: https://orcid.org/0009-0003-9269-7377)
- Michael Joseph Blaha (ORCID: https://orcid.org/0000-0001-5138-9683)
- Semenawit Burka
- Philipp Berning (ORCID: https://orcid.org/0000-0003-0442-3521)
- Omar Dzaye (ORCID: https://orcid.org/0000-0001-9483-3510)
- Zhiqi Yao (ORCID: https://orcid.org/0000-0001-6356-1524)
- Roger S. Blumenthal (ORCID: https://orcid.org/0000-0003-1910-3168)
- Richeal Asante
Institutions
- Johns Hopkins University (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- American Journal of Hypertension
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1093/ajh/hpaf190
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00